Arrail Group (“Arrail” or the “Company), a leading dental service provider in China, announced that it has closed its Series E financing, with a transaction value of nearly $200M. The transaction was led by Temasek, with participation from OrbiMed, Ward Ferry, Hina Group, Industrial Bank and Mirae Asset.
CEC Capital Group was the exclusive financial advisor on this transaction, and is proud to have advised Arrail since its Series A round of financing.
Established in 1999, Arrail Group was the first high-end dental clinic that introduced leading international best practices in dentistry to China. With over two decades in the market and a service philosophy of "Customers are Family Members", Arrail Group has become the absolute leader in China’s higher end dental service market by providing professional, personalized and comfortable dental care service. Currently they have over 100 clinics and hospitals across 16 cities under two brands, Arrail Dental and Rytime Dental. Arrail Group has serviced millions of patients since its establishment, and established significant partnerships with premium corporate clients including large MNCs and domestic companies.
Mr. Robert Zou, Founder and CEO of Arrail, commented, “When we started over 20 years ago, it was clear that there was a significant gap in the market with regards to dental care. While we have seen strong steady growth, China’s dental market is still relatively immature and under-saturated. With rapid economic growth in China and people's increasing awareness of oral health, the massively underserved dental market in China is reaching a tipping point. Our philosophy is to serve patients throughout their lifecycle, rather than pushing higher margin or unnecessary services. We appreciate the support of our investors, which enables us to realize our vision to provide high quality dental care for our family members across China.”
About Arrail Group
Arrail Dental, the first high-end dental service provider of Arrail group, was founded and located at Beijing CITIC Tower in 1999. With over 20 years’ development by upholding the service philosophy of "Customers are family members", Arrail Group has turned into a large chain-style medical service provider owning more than 100 clinics widespread in Beijing, Tianjin, Shanghai, Hangzhou, Shenzhen, Guangzhou, Xiamen, Chengdu, Chongqing, Xi'an, Qingdao, Changsha, Ji'nan, Wuxi, Dalian and with its two brands of "Arrail" and "Rytime". For more information on Arrail Group, please visit www.arrailgroup.com
Temasek is an investment company with a net portfolio value of S$306 billion (RMB1.52t) as at 31 March 2020. Their investment philosophy is anchored around four key themes: Transforming Economies; Growing Middle Income Populations; Deepening Comparative Advantages; and Emerging Champions. They actively seek sustainable solutions to address present and future challenges, as they capture investment and other opportunities that help to bring about a better, smarter and more sustainable world. Headquartered in Singapore, they have 11 offices around the world. For more information on Temasek, please visit www.temasek.com.sg
OrbiMed is a leading global healthcare investment firm, with $18 billion in assets under management across a range of private equity funds, public equity funds, and private credit/royalty funds. It invests across the healthcare industry, from start-ups to large multinational corporations. OrbiMed’s team of over 100 professionals are based in key markets around the world. For more information on OrbiMed, please visit www.orbimed.com
About Ward Ferry
Ward Ferry Management (BVI) Limited ("Ward Ferry") is a boutique investment management firm founded in 2000. Based in Hong Kong, Ward Ferry manages long-only equity funds that invest across Asia for global institutional investors. Ward Ferry's fundamentals-driven investment strategy follows a "private equity" approach to public markets investing by performing intensive on-the-ground primary research and targeting a multi-year investment horizon. For more information on Ward Ferry, please visit www.wardferry.com
About Hina Group
Hina Group is a Chinese financial advisor and investment manager, with over 100 professionals in Beijing and Shanghai. For more information on Hina Group, please visit www.hinagroup.com
About Industrial Bank
China Industrial International Asset Management ("CIIAM") is the equity investment platform under Industrial Bank Co. It practices the strategy of "Commercial Bank + Investment Bank", and strives to provide investee enterprises with comprehensive financial services, industrial resources and other empowerment to support the transformation and development of China's real economy. CIIAM focus on hard technology, consumer and healthcare sectors. For more information on CIIAM, please visit ciiam.com.cn
About Mirae Asset
Mirae Asset Global Investment was founded in 1997, and now is one of Asia’s leading independent financial services companies with 15 offices worldwide and $459bn AUM. Mirae Asset provides comprehensive financial services including private equity, public equity, insurances and fixed asset. In China market, Mirae mainly focus on high growth potential sectors such as healthcare, consumer and technology. For more information on Mirae Asset, please visit www.am.miraeasset.com
About CEC Capital Group
Founded in 2000, CEC Capital Group is a leading investment bank in China with a core focus on the TMT, consumer and healthcare sectors. Headquartered in Beijing with offices in Shanghai, Los Angeles and San Francisco, we provide M&A, capital raising, and asset management services to our clients both in and outside of China. CEC Capital has become the boutique investment bank with the most healthcare transactions in China for four consecutive years. Additionally, CEC Capital has a healthcare team with the largest number of investment bankers, the highest level of professionalism, and the most comprehensive industry coverage. For more information on CEC Capital Group, please visit www.ceccapitalgroup.com
Tel：+86 (10) 8519 2080
Fax：+86 (10) 8519 2078